collection
MENU ▼
Read by QxMD icon Read
search

Preeclampsia

shared collection
22 papers 500 to 1000 followers
By Chad Klauser Maternal Fetal Medicine physician in NYC
https://www.readbyqxmd.com/read/26342729/pre-eclampsia
#1
REVIEW
Ben W J Mol, Claire T Roberts, Shakila Thangaratinam, Laura A Magee, Christianne J M de Groot, G Justus Hofmeyr
Pre-eclampsia affects 3-5% of pregnancies and is traditionally diagnosed by the combined presentation of high blood pressure and proteinuria. New definitions also include maternal organ dysfunction, such as renal insufficiency, liver involvement, neurological or haematological complications, uteroplacental dysfunction, or fetal growth restriction. When left untreated, pre-eclampsia can be lethal, and in low-resource settings, this disorder is one of the main causes of maternal and child mortality. In the absence of curative treatment, the management of pre-eclampsia involves stabilisation of the mother and fetus, followed by delivery at an optimal time...
March 5, 2016: Lancet
https://www.readbyqxmd.com/read/26113232/oral-nifedipine-versus-intravenous-labetalol-for-severe-hypertension-during-pregnancy-a-systematic-review-and-meta-analysis
#2
REVIEW
S Shekhar, N Gupta, R Kirubakaran, P Pareek
BACKGROUND: Oral nifedipine is recommended along with labetalol and hydralazine for treatment of severe hypertension during pregnancy by most authorities. Although nifedipine is cheap and easily administered, the usage pattern among health care providers suggests a strong preference for labetalol despite lack of evidence for the same. OBJECTIVES: To determine the efficacy and safety of oral nifedipine for treatment of severe hypertension of pregnancy compared with intravenous labetalol...
January 2016: BJOG: An International Journal of Obstetrics and Gynaecology
https://www.readbyqxmd.com/read/25717062/uric-acid-determination-in-gestational-hypertension-is-it-as-effective-a-delineator-of-risk-as-proteinuria-in-high-risk-women
#3
Mandy J Schmella, Rebecca G Clifton, Andrew D Althouse, James M Roberts
We asked, is uric acid as effective as proteinuria at identifying perinatal risk in high-risk women with gestational hypertension? Uric acid was measured in samples obtained ≈4.6 weeks predelivery in 259 women with prior preeclampsia from the National Institute of Child Health and Human Development network study of low-dose aspirin to prevent preeclampsia. Participants were grouped according to the presence/absence of gestational hypertension (H), proteinuria (P), and hyperuricemia (U). Adverse perinatal outcomes were not different between H or U and women with normal values (normal blood pressure, urinary protein, and uric acid [NNN])...
October 2015: Reproductive Sciences
https://www.readbyqxmd.com/read/25548836/maternal-and-fetal-outcome-in-de-novo-preeclampsia-in-comparison-to-superimposed-preeclampsia-a-two-year-observational-study
#4
COMPARATIVE STUDY
Mohamed Rezk, Awni Gamal, Mahmoud Emara
AIM: To assess the maternal and fetal outcome in women with de novo preeclampsia (PE) in comparison to superimposed PE. STUDY DESIGN: This was a prospective 2-year observational study carried out at Menoufia University Hospital, Egypt, in which 164 patients out of 6472 pregnant women were diagnosed with PE (78 with de novo PE and 86 with superimposed PE). Enrolled patients were followed to assess the maternal and fetal outcome. RESULTS: There was a significant higher women with liver impairment and delivery by caesarean section in the de novo PE group (p < 0...
May 2015: Hypertension in Pregnancy
https://www.readbyqxmd.com/read/25200125/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-u-s-preventive-services-task-force-recommendation-statement
#5
Michael L LeFevre
DESCRIPTION: Update of the 1996 U.S. Preventive Services Task Force (USPSTF) recommendation on aspirin prophylaxis in pregnancy. METHODS: The USPSTF reviewed the evidence on the effectiveness of low-dose aspirin in preventing preeclampsia in women at increased risk and in decreasing adverse maternal and perinatal health outcomes, and assessed the maternal and fetal harms of low-dose aspirin during pregnancy. POPULATION: This recommendation applies to asymptomatic pregnant women who are at increased risk for preeclampsia and who have no prior adverse effects with or contraindications to low-dose aspirin...
December 2, 2014: Annals of Internal Medicine
https://www.readbyqxmd.com/read/25399526/lmwh-to-prevent-placenta-mediated-pregnancy-complications-an-update
#6
REVIEW
Lisa Duffett, Marc Rodger
Placenta-mediated pregnancy complications, including preeclampsia, placental abruption, intrauterine growth restriction/small for gestational age and recurrent or late pregnancy loss, affect over 5% of pregnancies and can result in significant maternal and perinatal morbidity and mortality. These complications have been suggested to at least partly arise from placental insufficiency, possibly as a result of inappropriate coagulation activation. This association has led to the hypothesis that anticoagulant therapy, such as low molecular weight heparin, might reduce their occurrence...
March 2015: British Journal of Haematology
https://www.readbyqxmd.com/read/24927294/diagnosis-evaluation-and-management-of-the-hypertensive-disorders-of-pregnancy-executive-summary
#7
Laura A Magee, Anouk Pels, Michael Helewa, Evelyne Rey, Peter von Dadelszen
OBJECTIVE: This executive summary presents in brief the current evidence assessed in the clinical practice guideline prepared by the Canadian Hypertensive Disorders of Pregnancy Working Group and published by Pregnancy Hypertension (http://www.pregnancyhypertension.org/article/S2210-7789(14)00004-X/fulltext) to provide a reasonable approach to the diagnosis, evaluation, and treatment of the hypertensive disorders of pregnancy. EVIDENCE: Published literature was retrieved through searches of Medline, CINAHL, and The Cochrane Library in March 2012 using appropriate controlled vocabulary (e...
May 2014: Journal of Obstetrics and Gynaecology Canada: JOGC, Journal D'obstétrique et Gynécologie du Canada: JOGC
https://www.readbyqxmd.com/read/24150027/hypertension-in-pregnancy-report-of-the-american-college-of-obstetricians-and-gynecologists%C3%A2-task-force-on-hypertension-in-pregnancy
#8
(no author information available yet)
No abstract text is available yet for this article.
November 2013: Obstetrics and Gynecology
https://www.readbyqxmd.com/read/22389120/preeclampsia-and-hypertensive-disease-in-pregnancy-their-contributions-to-cardiovascular-risk
#9
REVIEW
Carolina Valdiviezo, Vesna D Garovic, Pamela Ouyang
More women than men die each year of cardiovascular disease, which remains the leading cause of death in the United States. Sex-specific factors, including pregnancy-related disorders, should be considered when assessing cardiovascular (CV) risk in women. Hypertensive disorders of pregnancy have been associated with CV risk later in life and may identify women in whom earlier primary prevention may reduce their risk. This article reviews the physiologic changes in blood pressure during pregnancy, current definitions of hypertensive diseases of pregnancy and preeclampsia, and postulated pathophysiologic mechanisms leading to preeclampsia that might contribute to later CV risk...
March 2012: Clinical Cardiology
https://www.readbyqxmd.com/read/23973398/incidence-of-preeclampsia-risk-factors-and-outcomes-associated-with-early-versus-late-onset-disease
#10
Sarka Lisonkova, K S Joseph
OBJECTIVE: The population-based incidence of early-onset (<34 weeks) and late-onset preeclampsia (≥34 weeks) has not been adequately studied. We examined the gestational age-specific incidence of preeclampsia onset and identified the associated risk factors and birth outcomes. STUDY DESIGN: All singleton deliveries in Washington State, 2003-2008 (n = 456,668), were included, and preeclampsia onset was determined from hospital records linked to birth certificates...
December 2013: American Journal of Obstetrics and Gynecology
https://www.readbyqxmd.com/read/25135649/treatment-of-preeclampsia-current-approach-and-future-perspectives
#11
REVIEW
Ecaterina Berzan, Ross Doyle, Catherine M Brown
Hypertension is the most common medical disorder encountered during pregnancy, occurring in about 6-8 % of pregnancies. Preeclampsia is a pregnancy-specific disorder that occurs after 20 weeks' gestation, characterized by hypertension and proteinuria. Preeclampsia can also occur superimposed upon chronic hypertension. Eclampsia is the convulsive form of preeclampsia, and affects 0.1 % of all pregnancies. In low-income and middle-income countries, preeclampsia and eclampsia are associated with 10-15 % of direct maternal deaths...
September 2014: Current Hypertension Reports
https://www.readbyqxmd.com/read/23916027/hypertensive-crisis-during-pregnancy-and-postpartum-period
#12
REVIEW
Gloria T Too, James B Hill
Hypertension affects 10% of pregnancies, many with underlying chronic hypertension, and approximately 1-2% will undergo a hypertensive crisis at some point during their lives. Hypertensive crisis includes hypertensive urgency and emergency; the American College of Obstetricians and Gynecologists describes a hypertensive emergency in pregnancy as persistent (lasting 15 min or more), acute-onset, severe hypertension, defined as systolic BP greater than 160 mmHg or diastolic BP >110 mmHg in the setting of pre-eclampsia or eclampsia...
August 2013: Seminars in Perinatology
https://www.readbyqxmd.com/read/25001023/pregnancy-outcome-and-placental-findings-in-pregnancies-complicated-by-fetal-growth-restriction-with-and-without-preeclampsia
#13
COMPARATIVE STUDY
Michal Kovo, Letizia Schreiber, Osnat Elyashiv, Avi Ben-Haroush, Golan Abraham, Jacob Bar
OBJECTIVE: To compare pregnancy outcome and placental pathology in pregnancies complicated by fetal growth restriction (FGR) with and without preeclampsia. METHODS: Labor, fetal/neonatal outcome, and placental pathology parameters from neonates with a birth weight below the 10 th percentile (FGR), born between 24 and 42 weeks of gestation, were reviewed. Results were compared between pregnancies complicated with preeclampsia (hypertensive FGR [H-FGR]) to those without preeclampsia (normotensive FGR [N-FGR])...
March 2015: Reproductive Sciences
https://www.readbyqxmd.com/read/25003615/pre-eclampsia-part-1-current-understanding-of-its-pathophysiology
#14
REVIEW
Tinnakorn Chaiworapongsa, Piya Chaemsaithong, Lami Yeo, Roberto Romero
Pre-eclampsia is characterized by new-onset hypertension and proteinuria at ≥20 weeks of gestation. In the absence of proteinuria, hypertension together with evidence of systemic disease (such as thrombocytopenia or elevated levels of liver transaminases) is required for diagnosis. This multisystemic disorder targets several organs, including the kidneys, liver and brain, and is a leading cause of maternal and perinatal morbidity and mortality. Glomeruloendotheliosis is considered to be a characteristic lesion of pre-eclampsia, but can also occur in healthy pregnant women...
August 2014: Nature Reviews. Nephrology
https://www.readbyqxmd.com/read/25004349/maternal-proteinuria-in-twin-compared-with-singleton-pregnancies
#15
COMPARATIVE STUDY
Sarah S Osmundson, Richard A Lafayette, Raffick A Bowen, Valerie C Roque, Matthew J Garabedian, Natali Aziz
OBJECTIVE: To compare 24-hour urinary protein excretion in twin and singleton pregnancies not complicated by hypertension. METHODS: We prospectively evaluated mean 24-hour urinary protein excretion in twin and singleton pregnancies between 24 0/7 weeks and 36 0/7 weeks of gestation. Women with urinary tract infections, chronic hypertension, pregestational diabetes, and renal or autoimmune diseases were excluded. Collection adequacy was assessed by urinary creatinine excretion adjusted for maternal weight...
August 2014: Obstetrics and Gynecology
https://www.readbyqxmd.com/read/24960615/calcium-supplementation-during-pregnancy-for-preventing-hypertensive-disorders-and-related-problems
#16
REVIEW
G Justus Hofmeyr, Theresa A Lawrie, Alvaro N Atallah, Lelia Duley, Maria R Torloni
BACKGROUND: Pre-eclampsia and eclampsia are common causes of serious morbidity and death. Calcium supplementation may reduce the risk of pre-eclampsia, and may help to prevent preterm birth. OBJECTIVES: To assess the effects of calcium supplementation during pregnancy on hypertensive disorders of pregnancy and related maternal and child outcomes. SEARCH METHODS: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (28 March 2013) and contacted study authors for more data where possible...
2014: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/24881822/the-relationship-between-preeclampsia-and-intrauterine-growth-restriction-in-twin-pregnancies
#17
Nathan S Fox, Daniel H Saltzman, Sandip Oppal, Chad K Klauser, Simi Gupta, Andrei Rebarber
OBJECTIVE: Preeclampsia and intrauterine growth restriction (IUGR) are correlated in singleton pregnancies. The objective of this study was to estimate their relationship in twin pregnancies. STUDY DESIGN: Cohort of 578 patients with twin pregnancies delivered by 1 maternal fetal medicine practice from 2005-2013. Patients with chronic hypertension, monochorionic-monoamniotic placentation, twin-twin transfusion, and major congenital anomalies were excluded. Standard definitions were used for gestational hypertension and preeclampsia...
October 2014: American Journal of Obstetrics and Gynecology
https://www.readbyqxmd.com/read/24832366/oral-antihypertensive-therapy-for-severe-hypertension-in-pregnancy-and-postpartum-a-systematic-review
#18
REVIEW
T Firoz, L A Magee, K MacDonell, B A Payne, R Gordon, M Vidler, P von Dadelszen
BACKGROUND: Pregnant and postpartum women with severe hypertension are at increased risk of stroke and require blood pressure (BP) reduction. Parenteral antihypertensives have been most commonly studied, but oral agents would be ideal for use in busy and resource-constrained settings. OBJECTIVES: To review systematically, the effectiveness of oral antihypertensive agents for treatment of severe pregnancy/postpartum hypertension. SEARCH STRATEGY: A systematic search of MEDLINE, EMBASE and the Cochrane Library was performed...
September 2014: BJOG: An International Journal of Obstetrics and Gynaecology
https://www.readbyqxmd.com/read/24728212/aspirin-plus-calcium-supplementation-to-prevent-superimposed-preeclampsia-a-randomized-trial
#19
RANDOMIZED CONTROLLED TRIAL
E V Souza, M R Torloni, A N Atallah, G M S dos Santos, L Kulay, N Sass
Preeclampsia is an important cause of maternal and perinatal morbidity and mortality. Previous studies have tested calcium supplementation and aspirin separately to reduce the incidence of preeclampsia but not the effects of combined supplementation. The objective of this study was to investigate the effectiveness of aspirin combined with calcium supplementation to prevent preeclampsia in women with chronic hypertension. A double-blind, placebo-controlled randomized clinical trial was carried out at the antenatal clinic of a large university hospital in São Paulo, SP, Brazil...
May 2014: Brazilian Journal of Medical and Biological Research, Revista Brasileira de Pesquisas Médicas e Biológicas
https://www.readbyqxmd.com/read/24866995/uspstf-low-dose-aspirin-may-help-reduce-risk-of-preeclampsia
#20
Rebecca Voelker
No abstract text is available yet for this article.
May 2014: JAMA: the Journal of the American Medical Association
label_collection
label_collection
2101
1
2
2014-05-31 14:43:09
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"